With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
June 27, 2017. A population study published in JAMA adds to our knowledge that quality of life outcomes heavily depend on the treatment modality used to treat prostate cancer. You may recall the ProtecT trial back in 2016. This more recent report echoes many of those findings, namely: sexual dysfunction and incontinence come with surgery, urinary obstruction and frequency and more bowel problems come with radiation. So now we have even more data to arm our patients with informed decision-making. Counsel on.